Clues to renal sodium retention

Carattino, Marcelo D.; Passero, Christopher J.

doi:10.1152/ajprenal.00737.2010

Cited by 2 publications

(2 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Es soll eine Natriumexkretionsmenge von 80 -120 mEq/d angestrebt werden. Sinnvoll ist diese Messung bei Patienten, die den Zielblutdruck nicht erreichen oder deren Proteinurie schwer zu senken ist [14]. CKD und Hypertonie ebenfalls Mittel der ersten Wahl, umso mehr, als sie auch antiproteinurisch wirken.…”

Section: Kontrolle Des Salzkonsumsunclassified

Chronische Nierenerkrankungen – was der Praktiker wissen sollte

Dabers¹,

Weckmann²,

Chenot³

et al. 2017

Dtsch med Wochenschr

View full text Add to dashboard Cite

Chronic kidney disease (CKD) affects between 3 and 17 % of the population in Europe, especially elderly persons. CKD is a clinical syndrome which may develop in patients with e. g. diabetes mellitus, arterial hypertension or autoimmune diseases. A poorer renal function - especially in old age - is to be considered irrespective of the medication. Many antibiotics and painkillers require dose adjustments. Therapy should be done in a manner which is suitable for indication. Polypharmacy should be avoided as far as possible. Diuretics and RAAS inhibitors are useful drugs in therapy of CKD. Changes of lifestyle are important, so as weight reduction, restriction of salt and fructose, sufficient drinking, strict control of blood glucose, blood pressure and hypercholesterolaemia. Additional acute lesions have to be avoided ("acute-on-chronic renal failure").

show abstract

Section: Kontrolle Des Salzkonsumsunclassified

Chronische Nierenerkrankungen – was der Praktiker wissen sollte

Dabers¹,

Weckmann²,

Chenot³

et al. 2017

Dtsch med Wochenschr

View full text Add to dashboard Cite

show abstract

“…The achievement of this goal will consist in a sodium excretion of about 80-120 mEq of sodium/day. The monitoring of this urinary parameter is particularly important in those patients not achieving the blood pressure or proteinuria reduction [8]. High fructose intake (in the form of tablets or syrups) should be avoided because it increases renal sodium reabsorption and can worsen blood pressure control [9].…”

Section: Management Of Patients With the Mild Ckd (Stage 1-2 Kdoqi)mentioning

confidence: 99%

Management of patients with chronic kidney disease

Schena

2011

Intern Emerg Med

View full text Add to dashboard Cite

Chronic kidney disease (CKD) is a silent disease which worsens gradually to end-stage kidney disease (ESKD). US kidney disease outcomes quality initiative (KDOQI) guidelines indicate five stages of CKD based on the severity of kidney function which is assessed by estimating the glomerular filtration rate (GFR) by the modification of diet in renal disease (MDRD) formula. The management of CKD patients with mild renal damage (stage 1-2 KDOQI) is articulated on the reduction of proteinuria (<500 mg/day), reduction of sitting systolic and diastolic blood pressure (<130/80 mmHg), salt restriction diet, diuretics (furosemide, spironolactone), antihypertensive agents (ACE inhibitors or ARBs (angiotensin II receptor blockers) or both as first-line therapy), additional other antihypertensives (aliskiren, non-dihydropyridine calcium channel blockers, beta blockers), body weight reduction, cigarette smoking stopping, allopurinol therapy and non-use of some drugs (non-steroidal anti-inflammatory agents, acetaminophen, bisphosphonates, oral estrogens) and herbals. The management of CKD patients with moderate-severe renal damage (stage 3-5 KDOQI) is based on the above recommendations plus low protein diet, correction of hyperkalaemia, metabolic acidosis, and administration of vitamin D derivates and erythropoietin for the correction of mineral metabolism disorders and anemia, respectively. In conclusion, patients with CKD (stage 1-2 KDOQI) may be correctly managed by primary care physicians, individuals in stage 3-5 KDOQI need the supervision of nephrologists to assess those patients who progress to ESKD and require renal replacement therapy.

show abstract

Clues to renal sodium retention

Cited by 2 publications

References 32 publications

Chronische Nierenerkrankungen – was der Praktiker wissen sollte

Chronische Nierenerkrankungen – was der Praktiker wissen sollte

Management of patients with chronic kidney disease

Contact Info

Product

Resources

About